Phraxis Announces First-Ever Commercial Case of EndoForce™ Anastomotic Connector at Spartanburg Regional Medical Center

MINNEAPOLIS, Aug. 29, 2025 /PRNewswire/ -- Phraxis, Inc., a leader in vascular access innovation, today announced the successful completion of the first commercial case using the EndoForce™ Anastomotic Connector, marking a historic milestone in the treatment of dialysis patients worldwide.

The procedure, performed by Dr. Ari Kramer, Vascular Access Surgeon and early clinical pioneer of EndoForce™, took place at Spartanburg Regional Medical Center in Spartanburg, South Carolina.

EndoForce™, recently granted U.S. Food and Drug Administration (FDA) approval, is the first device of its kind designed to simplify vascular access creation by replacing hand-sewn surgical sutures with a precise, reproducible connector. The technology is compatible with all PTFE grafts and was studied extensively in the company's pivotal clinical trial.